Edwards Lifesciences Corp. affirmed its outlook for 2021.
The medical-device company said it still expects adjusted earnings to be between $2 and $2.20 a share. It also still expects between $4.9 billion and $5.3 billion in sales. According to FactSet, analysts are expecting $2.14 in adjusted earnings.
Edwards also said it expects between $1.1 billion and $1.2 billion in sales this quarter. For adjusted earnings, it is expecting between 43 cents a share and 50 cents a share. Analysts are expecting 50 cents a share in adjusted earnings.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.